CVAC - CureVac - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

557M

Cash

300.2M

Avg Qtr Burn

-66.21M

Short % of Float

6.11%

Insider Ownership

45.27%

Institutional Own.

21.68%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Flu SV Vaccine Details Influenza, Viral infection	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Avian Infuenza Vaccine Details Influenza, Viral infection	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.